Osseointegration Implants Market Research Report, by Product (Bone-anchored Prostheses, Dental Implants and Others), By Material Type (Metallic, Ceramic, Polymeric and Others), By End User (Hospitals, Ambulatory Surgical Clinics and Others), By Region (Americas, Europe, Asia Pacific and The Middle East and Africa) – Global Forecast Till 2027

Osseointegration Implants Market Overview:

The global osseointegration implants market is anticipated to expand at a notable CAGR of 6.4% during the forecast period of 2017-2023 and reach the valuation of USD 6.8 Bn by the end of 2023 from USD 4.7 Bn in 2017. Technological innovation in the healthcare sector is assisting in the creation of highly efficient and innovative therapies that give speedier relief from a variety of medical ailments. Osseointegration implants are utilized to create a direct functional and structural link between the bone and the surface of the artificial implant. With an expanding elderly population and the growing popularity of aesthetic dentistry.

The advancement of osseointegration technology has improved bone and joint replacement surgeries, as well as dental implants, and has improved prostheses for patients. The use of various materials to carry out the operation, as well as the capacity to offer stability to the implants and prostheses, is driving the growth of the worldwide osseointegration implant market.

Companies Covered

The key players operating in the Global Osseointegration Implants Market are Zimmer Biomet Holdings Inc., Dentsply Sirona Inc., Danaher Corporation, The Straumann Group, Henry Schein Inc., Stryker Corporation, NuVasive, Inc., William Demant Holding A/S, Cochlear Ltd., and Medtronic plc.

Market Report Overview

The MRFR's research report offers a detailed and unbiased analysis of the key market trends in the global Osseointegration Implants Market. It includes a detailed discussion on the current as well as historical market dynamics, consumer landscape, competitive landscape, growth opportunities and challenges backed by fact-based feedbacks. The types of products that are covered in the report on the global osseointegration implants market are bone-anchored prostheses, dental implants and others. The primary material types assessed in the report are metallic, ceramic, polymeric and others. The end-users that are covered in the report on the global osseointegration market include hospitals, ambulatory surgical clinics and others. All the sub-markets that are covered in the report on the global osseointegration implants market are profiled under four major regions such as the Americas, Europe, Asia Pacific and the Middle East and Africa, along with country-level analysis.

Osseointegration Implants Market Segmental Analysis

For the scope of the research report, MRFR offers an in-depth analysis of the global osseointegration implants market

• 
  

  By Product

  
  




• 
  

  Bone-anchored Prostheses

  
  


• 
  

  Dental Implants

  
  


• 
  

  Others

  
  




• 
  

  By Material Type

  
  




• 
  

  Metallic

  
  


• 
  

  Ceramic

  
  


• 
  

  Polymeric

  
  


• 
  

  Others

  
  




• 
  

  By End User

  
  




• 
  

  Hospitals

  
  


• 
  

  Ambulatory Surgical Clinics

  
  


• 
  

  Others

  
  




• 
  

  By Region

  
  




• 
  

  Americas

  
  


• 
  

  Europe

  
  


• 
  

  Asia Pacific

  
  


• 
  

  The Middle East and Africa

  
  

Research Methodology

MRFR employs its industry expertise for the deliverance of qualitative and quantitative analysis of market trends, growth opportunities, consumer landscape and challenges in order to ensure the accuracy and authenticity of the market foresight. Primary and secondary research processes are utilized for data collection through surveys and interviews with key opinion makers across the value chain and verification of collected data through inputs from SEC filings, white paper references, paid databases and other credible sources available in public domain. Top-down and bottom-up approaches ensure the quality, accuracy and objectivity of the research findings.Recent Development

Zimmer Biomet Holdings, Inc. (Zimmer Biomet) is a musculoskeletal healthcare medical device firm. The firm develops, manufactures, and sells orthopedic reconstructive products; biologics; sports medicine; extremities; and trauma goods; spine, craniomaxillofacial, and thoracic products; office-based technologies; dental implants; and associated surgical products. Orthopedic surgeons, oral surgeons, neurosurgeons, other specialists, dentists, stocking distributors, hospitals, healthcare dealers, and healthcare buying groups are all served by Zimmer Biomet.

The Straumann Group, headquartered in Basel, Switzerland, studies, develops, produces, and distributes dental implants, tools, biomaterials, CADCAM prostheses, digital equipment, software, and clear aligners for use in replacement, restorative, orthodontic, and preventative dentistry. The Straumann Group also provides services to the dental profession across the world, such as training and education, in conjunction with the International Team for Implantology (ITI) and the Latin American Institute of Dental Research and Education.